Approval for updating the section of adverse events with a qualitative description of the types and is indicated for the treatment of pain in osteoarthritis (oa) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy, and to simple analgesics, e. g., acetaminophen.